Background: The cellular mdm2 gene has transforming activity when over
expressed and is amplified in a variety of human tumors. At least part
of the transforming ability of the MDM2 protein is due to binding and
inactivating the p53 tumor suppressor protein. Additionally, this pro
tein forms a complex in vivo with the L5 ribosomal protein and its ass
ociated 5S ribosomal RNA and may be part of a ribosomal complex. Mater
ials and Methods: A RNA homopolymer binding assay and a SELEX procedur
e have been used to characterize the RNA-binding activity of MDM2. Res
ults: The MDM2 protein binds efficiently to the homopolyribonucleotide
poly(G) but not to other homopolyribonucleotides. This binding is ind
ependent of the interaction of MDM2 with the L5 protein, which occurs
through the central acidic domain of MDM2. An RNA SELEX procedure was
performed to identify specific RNA ligands that bind with high affinit
y to the human MDM2 (HDM2) protein. After 10 rounds of selection and a
mplification, a subset of RNA molecules that bound efficiently to HDM2
was isolated from a randomized pool. Sequencing of these selected lig
ands revealed that a small number of sequence motifs were selected. Th
e specific RNA binding occurs through the RING finger domain of the pr
otein. Furthermore, a single amino add substitution in the RING finger
domain, G446S, completely abolishes the specific RNA binding. Conclus
ions: These observations, showing that MDM2 binds the L5/5S ribosomal
ribonucleoprotein particle and can also bind to specific RNA sequences
or structures, suggest a role for MDM2 in translational regulation in
a cell.